Evolution of the Average Target: GlaxoSmithKline Pakistan Limited

Evolution of the Target Price: GlaxoSmithKline Pakistan Limited

Changes in Analyst Recommendations: GlaxoSmithKline Pakistan Limited

101171c8815f3.LCbqcUcWETXIkJ0-fa0McXxzx5Sa3ehzS2GcO6CSpXg.ThKjHyZ8RHqP-tp5H-E4Fzkr_sGplb4nAQaxQ_HnwRl_aqFHL1xlVqnq-g~07dbff49ca238cfa45a3857dfc79d899

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +53.58%
+13.37%
+0.97%
+6.38%
+6.56%
-4.33%
+31.43%
-11.33%
+3.68%
+4.99%
Average +10.53%
Weighted average by Cap. +6.86%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
325.69PKR
Average target price
510.00PKR
Spread / Average Target
+56.59%
High Price Target
510.00PKR
Spread / Highest target
+56.59%
Low Price Target
510.00PKR
Spread / Lowest Target
+56.59%

Analyst Consensus Detail

Consensus revision (last 18 months)

  1. Stock Market
  2. Stocks
  3. GLAXO Stock
  4. Consensus GlaxoSmithKline Pakistan Limited